期刊文献+

广州地区Burkitt’s淋巴瘤的临床病理特征及EB病毒感染状况(英文) 被引量:3

Clinicopathologic features and Epstein-Barr virus infection status of Burkitt's lymphoma in Guangzhou district
下载PDF
导出
摘要 背景与目的:散发性Burkitt's淋巴瘤(sporadic Burkitt's lymphoma,sBL)少见,中国sBL的EB病毒(Epstein-Barrvirus,EBV)感染状况尚未见报道。本研究探讨广州地区sBL的临床特点、形态学特征、免疫表型及EBV的感染状况。方法:分析总结21例sBL患者的临床资料,并作一系列免疫组织化学染色确定免疫表型,EBV编码的小RNA(EBV-encoded small RNAs,EBERs)原位杂交检测EBV感染情况。结果:中山大学肿瘤防治中心2000年1月~2007年10月收治的2416例非霍奇金淋巴瘤中,明确诊断21例sBL(0.87%)。男女之比为4.25:1(17/4);中位年龄23岁。21例患者中,19例(90.48%)有淋巴结侵犯;16例(76.19%)多部位受累;12例(57.14%)临床分期为Ⅲ/Ⅳ期;15例化疗或手术加化疗患者的2年生存率为56.00%。20例形态学上表现为经典BL,另1例为伴有浆细胞样分化的BL变异型。该21例sBL主要的免疫表型为sIgM+/CD20+/CD10+/Bcl-6+/Bcl-2-[或Bcl-6+(>95%)/Bcl-2+(<10%)]/TdT-/Ki-67+100%。20例可检测病例中,11例有少数肿瘤细胞(3%~20%)表达CD5。10例肿瘤(47.62%)呈P53蛋白过表达。6例(28.57%)肿瘤细胞感染EBV,表达EBNA1和EBERs,但不表达LMP1。EBV阳性及阴性病例在形态学和免疫表型上均无显著差异。结论:广州地区sBL少见,主要见于儿童及年轻成年男性。多数病例有淋巴结的侵犯。形态学及免疫表型与地方性BL类同。28.57%病例呈EBVI型潜伏感染。 Background and Objective: Sporadic Burkitt's lymphoma (sBL) is uncommon and its relation to Epstein-Barr virus (EBV) is unknown in China. This study was to investigate the clinical presentation, morphologic features, immunophenotype and EBV infection status of sBL in Guangzhou district, a prevalent area of EBV infection. Methods: The clinical data of 21 sBL patients were reviewed. A panel of immunohistochemical staining was performed and EBV-encoded small RNAs (EBERs) in situ hybridization was applied to identify EBV infection. Results: From January 2000 to October 2007, 21 cases (0.87%) of sBL were confirmed among 2416 cases of non-Hodgkin's lymphoma (NHL) in Sun Yat-sen University Cancer Center. Male to female ratio was 4.25 (17/4). The median age was 23 years. Of the 21 patients, 19 (90.48%) had lymph node(s) involvement; 16 (76.19%) had multiple sites involvement; 12 (57.14%) were at advanced stages (Ⅲ/Ⅳ ). The 2-year survival rate of 15 patients who received chemotherapy or resection plus chemotherapy was 56.00%. Twenty cases showed the prototypic morphology of sBL, and one was the variant of sBL with plasmacytoid differentiation. The main immunophenotype of these 21 sBLs was slgM+/CD20+/CD10+/Bcl- 6+/Bcl-2-[or Bcl-6+(〉95%)/Bcl-2^ +(〈10%) ]/TdT^-/Ki-67^+ 100%. Of 20 detectable cases, 11 showed CD5 expression in a few (3%-20%) tumor cells. P53 was overexpressed in ten cases (47.62%). Six cases (28.57%) had EBV infection, with EBNA1 and EBERs expression, but not LMPI. There were no significant differences in morphology and immunophenotype between EBV-positive and EBV-negative cases. Conclusions, sBL is uncommon in Guangzhou district, mainly seen in boys and young men. Most patients had lymph node (s) involvement, showing similar morphology and immunophenotype as that of endemic BL. Type I EBV latent infection is associated with 28.57% of cases.
出处 《癌症》 SCIE CAS CSCD 北大核心 2009年第8期805-812,共8页 Chinese Journal of Cancer
基金 Specific Disease Foundationfor Lymphoma of Sun Yat-sen University Cancer Center(No.2008-00652)~~
关键词 Burkitt’s淋巴瘤 临床病理特征 EB病毒 免疫表型 Burkitt's lymphoma, clinicopathologic features, Epstein-Barr virus, immunophenotype
  • 相关文献

参考文献2

二级参考文献19

  • 1肖畅,苏祖兰,吴秋良,郜红艺,方建晨,夏忠军,管忠震.根据WHO新分类对493例非霍奇金淋巴瘤的临床病理分析[J].中华病理学杂志,2005,34(1):22-27. 被引量:54
  • 2赵莎,刘卫平,王晓凌,张文燕,江炜,唐源,李甘地.结外鼻型NK/T细胞淋巴瘤中EB病毒潜伏膜蛋白1基因30bp碱基缺失的检测意义及其与预后的关系[J].中华病理学杂志,2005,34(11):720-723. 被引量:5
  • 3The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin′s Lymphoma. Blood, 1997, 89: 3909-3918.
  • 4Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of Multiple Proto-oncogenes in B-cell diffuse Large cell lymphoma. Nature, 2001, 412:341-346.
  • 5Harris NL, Stein H, Coupland SE, et al. New approaches to lymphoma diagnosis(am soc hematol educ program). Hematology, 2001, 194-220.
  • 6Camacho FI, Mollejo M, Mateo MS, et al. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. Am J Surg Pathol,2001, 25:1268-1276.
  • 7Jaffe ES, Harris NL, Stein H, et al.eds. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press,2001.
  • 8Anderson T, Bender RA, Fisher RI, et al. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term follow up. Cancer Treat Rep, 1977, 61:1057-1066.
  • 9Yegappan S,Schnitzer B,Hsi ED. Follicular lymphoma with marginal zone differentiation:microdissection demonstrates the t (14;18) in both the follicular and marginal zone components. Mod Pathol,2001,14:191-196.
  • 10Schmid U, Cogliatti SB, Diss TC, et al. Monocytoid/marginal zone -cell differentiation in follicle centre cell lymphoma. Histopathology, 1996, 29:201-208.

共引文献39

同被引文献19

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部